New recommendations for testing C-reactive protein (CRP) will change the way you assess cardiovascular risk

February 2003

New recommendations for testing C-reactive protein (CRP) will change the way you assess cardiovascular risk.

Traditional CRP tests are useful to diagnose rheumatoid arthritis, lupus, and other inflammatory diseases.

Now high-sensitivity CRP (hs-CRP) tests are recommended by the American Heart Assoc and CDC to help predict cardiovascular risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote